Dr. Martin Gleave, Urologist, Vancouver, BC

Dr Gleave is a Distinguished Professor and Chair of the Department of Urologic Sciences at UBC, and a British Columbia Leadership Chair. He is a clinician-scientist and urologic surgeon, and Co-Founder and Executive Director of the VPC, a UBC and National Centre of Excellence, publishing > 625 papers with >60,000 citations, an H-Index of 125, and attracting >$120M in research funding. He was appointed to the Order of Canada for his leadership role in developing new treatments for prostate cancer and for his research on mechanisms mediating treatment resistance in cancer. Dr. Gleave's clinical practice focuses on urologic oncology in a multi-disciplinary environment spanning localized and advanced cancers. His research characterizes molecular mechanisms mediating treatment resistance in cancer, focusing on adaptive survival responses that drive acquired treatment resistance, and designing combination co-targeting strategies to create conditional lethality and improve cancer control. He patented several anti-cancer drugs and founded OncoGenex Pharmaceuticals to develop OGX-011 and OGX-427, inhibitors of cytoprotective chaperones clusterin and Hsp27 which progressed to Phase III and Phase II trials world-wide. OncoGenex was awarded Canadian Biotech Company of the Year in 2010. Dr. Gleave also recently co-founded TRiADD and Sustained Therapeutics. Dr Gleave is the recipient of numerous awards, including the 2018 Dr. Chew Wei Memorial Prize in Cancer Research, the Huggins Medal from the SUO in 2018, the Richard Williams Award from the AUA in 2017, the Barringer Medal from the American Association of GU Surgeons; the Eugene Fuller Award from the American Urological Association in 2013; the Aubrey Tingle Prize from the Michael Smith Foundation for Health Research; and the NCIC William Rawls Award for contributions to cancer control in Canada; He was appointed a Distinguished University Scholar at UBC in 2003 and awarded a BC Leadership Chair in 2005. Dr Gleave was awarded the 2006 BC Biotech Award for Innovation and Achievement, and the 2007 BC Innovation Council Frontiers in Research Award.

Dr. Martin  Gleave , Urologist, Vancouver BC, V5Z 1L9

Dr. Martin  Gleave , Urologist, Vancouver BC, V5Z 1L9 Is in good standing with the College of Physicians and Surgeons of Canada,Dr. Martin  Gleave , Urologist, Vancouver BC, V5Z 1L9is in good standing with the Canadian Urological Society and the Canadian Medical Association

Keywords: Benign Prostatic Hypertrophy, Benign prostatic hyperplasia (BPH) , Colon Cancer Screening & Treatment , Prostate Cancer, Hypothyroidism, Laparoscopic Surgery, Obesity Prostate Cancer treatment 

Dr. Martin  Gleave , Urologist, Vancouver BC, V5Z 1L9

If you are looking for local services or  treatment froma local urologist   in the office or hospital from a Urologist, contact a provider such as ( Dr. Martin Gleave ) to inquire if they are accepting patients or you need a referral.   Phone number to book an appointment (604) 875-5603  ( Dr. Martin Gleave ) Is in good standing with the College of Physicians and Surgeons ( Dr. Martin Gleave ) Is in good standing with the Canadian Urological Society ( Dr. Martin Gleave ) Is in good standing with the Canadian Medical Association

Keywords: Cancer: BPH, Cancer: Prostate Nutrition, Cancer: Breast Cancer, Cancer: Colon and Rectal Cancer Cancer: Lung Cancer, Cancer: Melanoma, Cancer: Ovarian Cancer, Cancer: Prostate Cancer

The speaker in the video may have no association with ( Dr. Martin Gleave, Urologist Vancouver, BC ). 
( Dr. Martin Gleave, Urologist Vancouver, BC ), may talk about some of the conditions and some of the treatment options shown on the videos. Always talk with your Local Urologist  about the information you learnt from the videos in regards to Male incontinence Contino® treatments and procedures the Local Urologist  could  perform and if they would be appropriate for you. Remember good information from your Local Urologist  is the corner stone to understanding your condition or disease.

Health Talks:

Sexual preservation for BPH prostate surgery

Urology Practice isa great pleace to start to look into If you’re experiencing symptoms of male incontinence, a local urologist can help. A local urologist can ask about your symptoms and recommend further testing or male incontinence treatment. Urethral inserts like Contino® are temporarily inserted into the urethra (the tube which carries urine to the outside of the body) to prevent or reduce bladder leakage. Damage to the kidneys can lead to swelling in the hands and ankles, high blood pressure, and other symptoms. 

Please contact ( Dr. Martin Gleave, Urologist Vancouver, BC ) to enquire if this health care provider is accepting new patients. Prostate Cancer NOW is part of the Now Health Network and its focus is on muscular and skeletal  conditions.  In summary, there are many different treatments for prostate cancer.  Identifying the best treatment will depend on your specific situation and your preference after discussion with your doctor. It is not true Asian men have the lowest risk of developing prostate cancer. African men have the highest risk. Often seeing a local urologist in Toronto can help. 

Medications like alpha blockers don't actually treat BPH, they treat the symptoms by relaxing the muscle around the urethra, so thereby reducing some of the resistance.

Sometimes we will add in a second line medication in order to try and shrink the prostate. These medications are called the five alpha reductase inhibitors. So we have Proscar or Avodart These are medications which work by lowering the conversion of testosterone within the prostate. Over a period of 6 to 12 months, this can shrink the prostate by around 20%.